Nickan Research Institute Journal of Renal Endocrinology 2423-6438 9 1 2023 01 01 COVID-19 patients’ lung involvement severity as a predictor of kidney dysfunction and coagulopathy disorders e25096 e25096 10.34172/jre.2023.25096 EN Farinaz Fattahi Mohammad Reza Farnia https://orcid.org/0000-0002-4397-8661 Bareza Rezaei https://orcid.org/0000-0002-7210-4162 Hooman Rafiei https://orcid.org/0000-0002-8598-9836 Aisan Ghasemi Oskui https://orcid.org/0000-0002-0201-7629 Amir Mohammad Amiri https://orcid.org/0009-0001-2767-9362 Mohammad Reza Rezaei https://orcid.org/0000-0002-5166-9711 Journal Article 10.34172/jre.2023.25096 2023 03 23 2023 06 13 Introduction: Kidney dysfunction, coagulopathy disorders, and lung involvement are the most common disorders caused by the COVID-19 virus. Objectives: This study aimed to investigate the correlation of lung involvement severity with kidney dysfunction and coagulopathy disorders in COVID-19 patients. Patients and Methods: This descriptive-analytical study was conducted on 97 patients with COVID-19 referred to Imam Reza hospital in Kermanshah from December 2020 to June 2021. Lung involvement severity, kidney function tests, and coagulation laboratory data were collected. Logistic regression test was conducted to explore the correlation between lung involvement with kidney dysfunction and coagulopathy disorders. Results: Out of 97 patients, 53 (54.6%) were male, with a mean age of 59.31 ± 16.44 years. The correlation between lung involvement severity with kidney function tests, including, blood urea nitrogen, serum creatinine, and coagulation factors, including prothrombin time (PT), partial thromboplastin time (PTT), and D-dimer, were significant (P > 0.05). Lung involvement severity significantly predicted kidney dysfunction and coagulopathy disorders. Conclusion: Lung involvement severity would be able to predict kidney dysfunction and coagulopathy disorders in patients with COVID-19.